Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Optics Balzers, formerly known as Oerlikon Optics, is a global leader in the design and manufacture of customized optical thin-film coatings and components. The company provides critical technology for the life sciences and healthcare sectors, including high-precision filters for fluorescence microscopy, PCR thermal cycling, and flow cytometry. Their products enable high-sensitivity detection and precise light management in diagnostic and analytical instrumentation. Following its divestment from the Oerlikon Group in 2009 and its subsequent acquisition by Materion Corporation in 2020, the company now operates as Materion Balzers Optics. It serves major medical device OEMs from manufacturing sites in Liechtenstein, Germany, and Malaysia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Oerlikon Optics.